Cyclobenzaprine contraindications
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Contraindications
Hypersensitivity
Concomitant use of monoamine oxidase inhibitors
Myocardial infarction
Hypersensitivity
Cyclobenzaprine is contraindicated in patients with Hypersensitivity to any component of this product. Return to top
Concomitant use of monoamine oxidase inhibitors
Cyclobenzaprine is contraindicated in patients with concomitant use of monoamine oxidase (MAO) inhibitors or within 14 days after their discontinuation. Hyperpyretic crisis seizures, and deaths have occurred in patients receiving Cyclobenzaprine (or structurally similar tricyclic antidepressants) concomitantly with MAO inhibitor drugs. Return to top
Myocardial infarction
Cyclobenzaprine is contraindicated in patients whom are in the Acute recovery phase of myocardial infarction, and patients with arrhythmias, heart block or conduction disturbances, or congestive heart failure. Return to top
The content of this page is taken from the FDA package insert for this drug and should not be edited.
